Single User License
INR 161500
Site License
INR 323000
Corporate User License
INR 484500

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Cerebral Aneurysms Global Clinical Trials Review, H1, 2015

Cerebral Aneurysms Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2613CTIDB
  • |
  • Pages: 58
  • |
  • March 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Cerebral Aneurysms Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Cerebral Aneurysms Global Clinical Trials Review, H1, 2015" provides data on the Cerebral Aneurysms clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cerebral Aneurysms. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cerebral Aneurysms. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Introduction 5

Cerebral Aneurysms 5

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Countries Contributing to Clinical Trials in Asia-Pacific 9

Top Countries Contributing to Clinical Trials in Europe 10

Top Countries Contributing to Clinical Trials in North America 11

Top Countries Contributing to Clinical Trials in Middle East and Africa 12

Clinical Trials by G7 Countries: Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials 13

Clinical Trials by Phase in G7 Countries 14

Clinical Trials in G7 Countries by Trial Status 15

Clinical Trials by E7 Countries: Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials 16

Clinical Trials in E7 Countries by Trial Status 17

Clinical Trials by Phase 18

In Progress Trials by Phase 19

Clinical Trials by Trial Status 20

Clinical Trials by End Point Status 21

Subjects Recruited Over a Period of Time 22

Clinical Trials by Sponsor Type 23

Prominent Sponsors 24

Top Companies Participating in Cerebral Aneurysms Therapeutics Clinical Trials 25

Prominent Drugs 26

Clinical Trial Profiles 27

Clinical Trial Overview of Top Companies 27

Hope Pharmaceuticals, Inc. 27

Clinical Trial Overview of Hope Pharmaceuticals, Inc. 27

Edge Therapeutics, Inc. 28

Clinical Trial Overview of Edge Therapeutics, Inc. 28

Clinical Trial Overview of Top Institutes / Government 29

Rush University Medical Center 29

Clinical Trial Overview of Rush University Medical Center 29

Guangzhou University of Traditional Chinese Medicine 30

Clinical Trial Overview of Guangzhou University of Traditional Chinese Medicine 30

Isfahan University of Medical Sciences 31

Clinical Trial Overview of Isfahan University of Medical Sciences 31

Juntendo University School of Medicine 32

Clinical Trial Overview of Juntendo University School of Medicine 32

Kwong Wah Hospital 33

Clinical Trial Overview of Kwong Wah Hospital 33

Kyoto University 34

Clinical Trial Overview of Kyoto University 34

Mashhad University of Medical Sciences 35

Clinical Trial Overview of Mashhad University of Medical Sciences 35

Medical University of South Carolina 36

Clinical Trial Overview of Medical University of South Carolina 36

National Cerebral and Cardiovascular Center 37

Clinical Trial Overview of National Cerebral and Cardiovascular Center 37

Samsung Medical Center 38

Clinical Trial Overview of Samsung Medical Center 38

Five Key Clinical Profiles 39

Appendix 56

Abbreviations 56

Definitions 56

Research Methodology 57

Secondary Research 57

About GlobalData 58

Contact Us 58

Disclaimer 58

Source 58

List of Figures

Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Region (%), 2015* 6

Cerebral Aneurysms Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Cerebral Aneurysms Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Cerebral Aneurysms Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 9

Cerebral Aneurysms Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11

Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 13

Cerebral Aneurysms Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Cerebral Aneurysms Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15

Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 16

Cerebral Aneurysms Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 17

Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Phase (%), 2015* 18

Cerebral Aneurysms Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 19

Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20

Cerebral Aneurysms Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22

Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 23

Cerebral Aneurysms Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24

Cerebral Aneurysms Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25

Cerebral Aneurysms Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26

GlobalData Methodology 57

List of Tables

Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Region, 2015* 6

Cerebral Aneurysms Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Cerebral Aneurysms Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Cerebral Aneurysms Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9

Cerebral Aneurysms Therapeutics Clinical Trials, Europe, Top Countries, 2015* 10

Cerebral Aneurysms Therapeutics Clinical Trials, North America, Top Countries, 2015* 11

Cerebral Aneurysms Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 12

Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 13

Cerebral Aneurysms Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Cerebral Aneurysms Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15

Proportion of Cerebral Aneurysms to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 16

Cerebral Aneurysms Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 17

Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Phase, 2015* 18

Cerebral Aneurysms Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 19

Cerebral Aneurysms Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20

Cerebral Aneurysms Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21

Cerebral Aneurysms Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22

Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 23

Cerebral Aneurysms Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24

Cerebral Aneurysms Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25

Cerebral Aneurysms Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26

Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Hope Pharmaceuticals, Inc., 2015* 27

Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Edge Therapeutics, Inc., 2015* 28

Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Rush University Medical Center, 2015* 29

Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Guangzhou University of Traditional Chinese Medicine, 2015* 30

Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2015* 31

Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University School of Medicine, 2015* 32

Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Kwong Wah Hospital, 2015* 33

Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2015* 34

Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Mashhad University of Medical Sciences, 2015* 35

Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of South Carolina, 2015* 36

Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cerebral and Cardiovascular Center, 2015* 37

Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2015* 38

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Cerebral Aneurysms Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Cerebral Aneurysms, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com